349 related articles for article (PubMed ID: 12789288)
1. PTEN signaling pathways in melanoma.
Wu H; Goel V; Haluska FG
Oncogene; 2003 May; 22(20):3113-22. PubMed ID: 12789288
[TBL] [Abstract][Full Text] [Related]
2. Loss of PTEN promotes tumor development in malignant melanoma.
Stahl JM; Cheung M; Sharma A; Trivedi NR; Shanmugam S; Robertson GP
Cancer Res; 2003 Jun; 63(11):2881-90. PubMed ID: 12782594
[TBL] [Abstract][Full Text] [Related]
3. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27.
An HJ; Lee YH; Cho NH; Shim JY; Kim JY; Lee C; Kim SJ
Histopathology; 2002 Nov; 41(5):437-45. PubMed ID: 12405911
[TBL] [Abstract][Full Text] [Related]
4. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.
Besson A; Robbins SM; Yong VW
Eur J Biochem; 1999 Aug; 263(3):605-11. PubMed ID: 10469123
[TBL] [Abstract][Full Text] [Related]
5. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
Tsao H; Goel V; Wu H; Yang G; Haluska FG
J Invest Dermatol; 2004 Feb; 122(2):337-41. PubMed ID: 15009714
[TBL] [Abstract][Full Text] [Related]
6. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
Steelman LS; Bertrand FE; McCubrey JA
Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.
Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C
Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
Gu J; Tamura M; Yamada KM
J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
[TBL] [Abstract][Full Text] [Related]
9. Regulation of PTEN (phosphatase and tensin homolog deleted on chromosome 10) expression by estradiol and progesterone in human endometrium.
Guzeloglu-Kayisli O; Kayisli UA; Al-Rejjal R; Zheng W; Luleci G; Arici A
J Clin Endocrinol Metab; 2003 Oct; 88(10):5017-26. PubMed ID: 14557489
[TBL] [Abstract][Full Text] [Related]
10. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.
Weng LP; Brown JL; Eng C
Hum Mol Genet; 2001 Mar; 10(6):599-604. PubMed ID: 11230179
[TBL] [Abstract][Full Text] [Related]
11. Enhanced protein kinase B/Akt signalling in pituitary tumours.
Musat M; Korbonits M; Kola B; Borboli N; Hanson MR; Nanzer AM; Grigson J; Jordan S; Morris DG; Gueorguiev M; Coculescu M; Basu S; Grossman AB
Endocr Relat Cancer; 2005 Jun; 12(2):423-33. PubMed ID: 15947113
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop.
Kim S; Domon-Dell C; Kang J; Chung DH; Freund JN; Evers BM
J Biol Chem; 2004 Feb; 279(6):4285-91. PubMed ID: 14623898
[TBL] [Abstract][Full Text] [Related]
13. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
14. PTEN modulates insulin-like growth factor II (IGF-II)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF-II expression in hepatoma cells.
Kang-Park S; Lee YI; Lee YI
FEBS Lett; 2003 Jun; 545(2-3):203-8. PubMed ID: 12804776
[TBL] [Abstract][Full Text] [Related]
15. PTEN regulatory functions in tumor suppression and cell biology.
Chu EC; Tarnawski AS
Med Sci Monit; 2004 Oct; 10(10):RA235-41. PubMed ID: 15448614
[TBL] [Abstract][Full Text] [Related]
16. PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells.
Stewart AL; Mhashilkar AM; Yang XH; Ekmekcioglu S; Saito Y; Sieger K; Schrock R; Onishi E; Swanson X; Mumm JB; Zumstein L; Watson GJ; Snary D; Roth JA; Grimm EA; Ramesh R; Chada S
Mol Med; 2002 Aug; 8(8):451-61. PubMed ID: 12435856
[TBL] [Abstract][Full Text] [Related]
17. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
18. PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.
Kim S; Domon-Dell C; Wang Q; Chung DH; Di Cristofano A; Pandolfi PP; Freund JN; Evers BM
Gastroenterology; 2002 Oct; 123(4):1163-78. PubMed ID: 12360479
[TBL] [Abstract][Full Text] [Related]
19. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
Li DM; Sun H
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
[TBL] [Abstract][Full Text] [Related]
20. Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas.
Qiao J; Kang J; Cree J; Evers BM; Chung DH
Ann Surg; 2005 May; 241(5):684-91; discussion 691-2. PubMed ID: 15849504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
